Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Mental Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00320268
What this trial is testing

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca 600
Testing effectiveness (Phase 2)Study completedNCT04471818
What this trial is testing

Ketamine or Placebo in Patients With Major Depression and Advanced Cancer

Who this might be right for
Major Depressive DisorderAdvanced Cancer
Instituto Nacional de Cancerologia de Mexico 19
Post-approval studies (Phase 4)Study completedNCT02051413
What this trial is testing

Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)

Who this might be right for
Major Depressive DisorderMajor Depressive Episode
Institut National de la Santé Et de la Recherche Médicale, France 67
Not applicableStudy completedNCT03718013
What this trial is testing

Efficacy and Safety of Accelerated Transcranial Magnetic Stimulation With H1-coil (dTMS)

Who this might be right for
Major Depressive Disorder
Sveti Ivan Psychiatric Hospital 118
Not applicableUnknownNCT05210140
What this trial is testing

Personalized Escitalopram Dosing in Patients With Depression

Who this might be right for
Depressive Disorder, Major
University of Belgrade 148
Not applicableStudy completedNCT01292889
What this trial is testing

Study of Genes in Relation to Seasonal Affective Disorder and Major Depressive Disorder

Who this might be right for
Seasonal Affective Disorder
University of Pittsburgh 30
Testing effectiveness (Phase 2)Study completedNCT00167310
What this trial is testing

Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation

Who this might be right for
SchizophreniaSchizoaffective DisorderMajor Depression+2 more
University of Pittsburgh 57
Not applicableLooking for participantsNCT06743711
What this trial is testing

Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project

Who this might be right for
Severe Mental IllnessSchizophrenia Spectrum &Amp; Other Psychotic DisordersBipolar Affective Disorder
Bjorn H. Ebdrup 75
Large-scale testing (Phase 3)Study completedNCT01318434
What this trial is testing

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Who this might be right for
Major Depressive Disorder
Euthymics BioScience, Inc. 342
Not applicableStudy completedNCT02739932
What this trial is testing

Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study

Who this might be right for
Psychotic DisordersDepressive Disorder, MajorBipolar Disorder
University of Calgary 243
Large-scale testing (Phase 3)Study completedNCT04533529
What this trial is testing

Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 588
Post-approval studies (Phase 4)Study completedNCT01477931
What this trial is testing

Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features

Who this might be right for
Depressive Disorder, Major
Chi-Un Pae 50
Large-scale testing (Phase 3)Study completedNCT00322153
What this trial is testing

The Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Dementia of the Alzheimer's Type
Forest Laboratories 677
Testing effectiveness (Phase 2)Study completedNCT05157945
What this trial is testing

ALTO-300 in Depression (ALTO-300-004)

Who this might be right for
Major Depressive Disorder
Alto Neuroscience 148
Large-scale testing (Phase 3)Study completedNCT00104611
What this trial is testing

Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Neuronetics 286
Not applicableLooking for participantsNCT04191811
What this trial is testing

Investigating Neural Response Variability as a Single-patient Predictor of Successful CBT in Clinical Psychiatry

Who this might be right for
Psychiatric DisorderDepressionAnxiety Disorders+1 more
Karolinska Institutet 150
Not applicableEnrolling By InvitationNCT06792175
What this trial is testing

Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models

Who this might be right for
Autism Spectrum DisorderDepression - Major Depressive DisorderAnxiety, Generalized+5 more
Psyrin Inc. 500
Not applicableStudy completedNCT04218981
What this trial is testing

Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders

Who this might be right for
Common Mental Disorder
Central South University 200
Testing effectiveness (Phase 2)Study completedNCT01381107
What this trial is testing

ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT03756129
What this trial is testing

Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression

Who this might be right for
Depressive Disorder, Treatment-Resistant
Novartis Pharmaceuticals 70
Next Page